Anil Suryaprasad1, Kathy K Byrd, John T Redd, David G Perdue, M Michele Manos, Brian J McMahon. 1. Anil Suryaprasad and Kathy K. Byrd are with the Division of Viral Hepatitis; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention; Centers for Disease Control and Prevention (CDC); US Department of Health and Human Services; Atlanta, GA. John T. Redd is with the Santa Fe Public Health Service Indian Hospital, Indian Health Service, US Department of Health and Human Services, Santa Fe, NM. David G. Perdue is with the American Indian Cancer Foundation and Minnesota Gastroenterology PA, Minneapolis. M. Michele Manos is with the Kaiser Permanente Division of Research, Oakland, CA. Brian J. McMahon is with the Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AL.
Abstract
OBJECTIVES: We compared chronic liver disease (CLD) mortality from 1999 to 2009 between American Indians and Alaska Natives (AI/ANs) and Whites in the United States after improving CLD case ascertainment and AI/AN race classification. METHODS: We defined CLD deaths and causes by comprehensive death certificate-based diagnostic codes. To improve race classification, we linked US mortality data to Indian Health Service enrollment records, and we restricted analyses to Contract Health Service Delivery Areas and to non-Hispanic populations. We calculated CLD death rates (per 100,000) in 6 geographic regions. We then described trends using linear modeling. RESULTS: CLD mortality increased from 1999 to 2009 in AI/AN persons and Whites. Overall, the CLD death rate ratio (RR) of AI/AN individuals to Whites was 3.7 and varied by region. The RR was higher in women (4.7), those aged 25 to 44 years (7.4), persons residing in the Northern Plains (6.4), and persons dying of cirrhosis (4.0) versus hepatocellular carcinoma (2.5), particularly those aged 25 to 44 years (7.7). CONCLUSIONS: AI/AN persons had greater CLD mortality, particularly from premature cirrhosis, than Whites, with variable mortality by region. Comprehensive prevention and care strategies are urgently needed to stem the CLD epidemic among AI/AN individuals.
OBJECTIVES: We compared chronic liver disease (CLD) mortality from 1999 to 2009 between American Indians and Alaska Natives (AI/ANs) and Whites in the United States after improving CLD case ascertainment and AI/AN race classification. METHODS: We defined CLD deaths and causes by comprehensive death certificate-based diagnostic codes. To improve race classification, we linked US mortality data to Indian Health Service enrollment records, and we restricted analyses to Contract Health Service Delivery Areas and to non-Hispanic populations. We calculated CLD death rates (per 100,000) in 6 geographic regions. We then described trends using linear modeling. RESULTS: CLD mortality increased from 1999 to 2009 in AI/AN persons and Whites. Overall, the CLD death rate ratio (RR) of AI/AN individuals to Whites was 3.7 and varied by region. The RR was higher in women (4.7), those aged 25 to 44 years (7.4), persons residing in the Northern Plains (6.4), and persons dying of cirrhosis (4.0) versus hepatocellular carcinoma (2.5), particularly those aged 25 to 44 years (7.7). CONCLUSIONS: AI/AN persons had greater CLD mortality, particularly from premature cirrhosis, than Whites, with variable mortality by region. Comprehensive prevention and care strategies are urgently needed to stem the CLD epidemic among AI/AN individuals.
Authors: Amy S Neumeister; LaVada E Pilcher; Judi M Erickson; Lora L Langley; Mary M Murphy; Nicole M Haukaas; Mark E Mailliard; Jennifer L Larsen Journal: J Natl Med Assoc Date: 2007-04 Impact factor: 1.798
Authors: Gregory L Armstrong; Annemarie Wasley; Edgar P Simard; Geraldine M McQuillan; Wendi L Kuhnert; Miriam J Alter Journal: Ann Intern Med Date: 2006-05-16 Impact factor: 25.391
Authors: Charles L Wiggins; David K Espey; Phyllis A Wingo; Judith S Kaur; Robin Taylor Wilson; Judith Swan; Barry A Miller; Melissa A Jim; Janet J Kelly; Anne P Lanier Journal: Cancer Date: 2008-09-01 Impact factor: 6.860
Authors: Melissa A Jim; David G Perdue; Lisa C Richardson; David K Espey; John T Redd; Howard J Martin; Sandy L Kwong; Janet J Kelly; Jeffrey A Henderson; Faruque Ahmed Journal: Cancer Date: 2008-09-01 Impact factor: 6.860
Authors: David K Espey; Melissa A Jim; Nathaniel Cobb; Michael Bartholomew; Tom Becker; Don Haverkamp; Marcus Plescia Journal: Am J Public Health Date: 2014-04-22 Impact factor: 9.308
Authors: Rodney C Haring; Melissa A Jim; Deborah Erwin; Judith Kaur; Whitney Ann E Henry; Marissa L Haring; Dean S Seneca Journal: Cancer Health Disparities Date: 2018-06-29
Authors: Tyler M Dougherty; Amanda E Janitz; Mary B Williams; Sydney A Martinez; Michael T Peercy; David F Wharton; Julie Erb-Alvarez; Janis E Campbell Journal: J Public Health Manag Pract Date: 2019 Sep/Oct
Authors: Jasmine L Jacobs-Wingo; David K Espey; Amy V Groom; Leslie E Phillips; Donald S Haverkamp; Sandte L Stanley Journal: Am J Public Health Date: 2016-02-18 Impact factor: 9.308
Authors: Stephanie C Melkonian; Dornell Pete; Melissa A Jim; Donald Haverkamp; Charles L Wiggins; Michael G Bruce; Mary C White Journal: Am J Gastroenterol Date: 2020-12 Impact factor: 12.045